THCX logo

THCX The Cannabis ETF

New York Stock Exchange Arca · Asset Management · Financial Services

$16.60
+0.06 (+0.35%)

This Exchange Traded Fund (ETF) concentrates its investments within the cannabis sector. It aims to allocate a minimum of 80% of its total capital to the specific securities that make up its benchmark index. Furthermore, under typical market conditions, at least 80% of its net assets, including any funds borrowed for investment, will be directed into publicly traded common stocks or American Depos…

Market Cap: $12.90M

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

50
3078126173
Aug 7Aug 14

Quote

Day Range
$16.53 – $16.74
52-Week Range
$14.90 – $23.22
Volume
$348.8K
Market Cap
$12.90M
50-Day Avg
$17.00
200-Day Avg
$17.41
Prev Close
$16.54
Open
$16.64

Valuation & Ratios

P/E Ratio
EPS
P/B Ratio
P/S Ratio
Debt/Equity
Current Ratio
Dividend Yield
Gross Margin

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Social Signal Score

60
5d
57
5 mentions
30d
61
8 mentions
60d
61
8 mentions
90d
61
8 mentions
news: 8

Valuation

THCXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (8)

  • Newsbusinesswire.com·1d ago·Neutral

    Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice (“EU GMP”) certification from the

    View source ↗
  • Newsprnewswire.com·1d ago·Neutral

    IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results TORONTO and GLIL YAM, Israel, Aug. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), today announced its financial results for the three and six months ended June 30, 2026. All amounts are reported in Canadian dollars, unless otherwise stated.

    View source ↗
  • Newsmarketbeat.com·3d ago·Negative

    Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts Canopy Growth NASDAQ: CGC is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and acquiring MTL Cannabis, President and CEO Luc Mongeau said during a Canaccord Genuity presentation.

    View source ↗
  • Newsseekingalpha.com·4d ago·Positive

    Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels Village Farms International, Inc. reported strong Q2 financial results with record international cannabis sales. The company has expanded its Canadian and Netherlands grow facilities, which will continue to drive revenue and lower operating costs. VFF stock remains undervalued with a strong forward outlook and a strong balance sheet.

    View source ↗
  • Newsfool.com·4d ago·Positive

    Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making? Canopy's balance sheet is finally improving. Medical cannabis is driving the strongest growth.

    View source ↗
  • Newsseekingalpha.com·5d ago·Positive

    Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy Trulieve Cannabis (TRLV) is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Recent catalysts include a $50 million share repurchase program and a profitable Q1 2026 with $42 million in free cash flow. Reclassification of medical marijuana to Schedule III removes the 280E tax burden, providing a major earnings and cash flow tailwind for TRLV.

    View source ↗
  • Newsmarketbeat.com·6d ago·Neutral

    Trulieve Cannabis Q2 Earnings Call Highlights Trulieve Cannabis NYSE: TRLV reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company's June listing on the New York Stock Exchange.

    View source ↗
  • Newsseekingalpha.com·7d ago·Positive

    Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript

    View source ↗